GVT
REGN icon

Genesee Valley Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Genesee Valley Trust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$1.42M Buy
4,420
+344
+8% +$120K 0.58% 33
2017
Q4 		$1.53M Sell
4,076
-259
-6% -$105K 0.64% 31
2017
Q3 		$1.94M Sell
4,335
-960
-18% -$457K 0.79% 24
2017
Q2 		$2.6M Buy
5,295
+766
+17% +$335K 1.1% 15
2017
Q1 		$1.75K Buy
4,529
+1,642
+57% +$609K 1.2% 22
2016
Q4 		$1.06K Sell
2,887
-82
-3% -$31.2K 0.75% 39
2016
Q3 		$1.19M Sell
2,969
-36
-1% -$14.4K 0.73% 32
2016
Q2 		$1.05M Buy
3,005
+61
+2% +$23.5K 0.68% 40
2016
Q1 		$1.06M Sell
2,944
-28
-0.9% -$11.5K 0.72% 38
2015
Q4 		$1.61M Buy
2,972
+117
+4% +$63.4K 1.06% 19
2015
Q3 		$1.33M Buy
2,855
+19
+0.7% +$10.2K 0.88% 24
2015
Q2 		$1.45M Sell
2,836
-219
-7% -$107K 0.93% 22
2015
Q1 		$1.38M Buy
3,055
+62
+2% +$26.3K 0.85% 25
2014
Q4 		$1.23M Buy
2,993
+9
+0.3% +$3.54K 0.79% 29
2014
Q3 		$1.08M Buy
2,984
+1,933
+184% +$648K 0.67% 32
2014
Q2 		$297K Sell
1,051
-11
-1% -$3.26K 0.18% 200
2014
Q1 		$319K Buy
+1,062
New +$327K 0.2% 157

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Genesee Valley Trust's REGN Position: Q1 2018 in Review

Genesee Valley Trust increased its Regeneron Pharmaceuticals (REGN) stake by 8.4% in Q1 2018, buying an estimated $120K and bringing the position to 4,420 shares worth $1.42M. The position accounts for 0.58% of the portfolio, ranked #33.

Genesee Valley Trust first reported a position in REGN in Q1 2014 and has held it in 17 quarters since. The position peaked at $2.6M in Q2 2017. 619 funds tracked by Wall St. Rank hold REGN as of Q1 2018.

  • Genesee Valley Trust held 4,420 shares of Regeneron Pharmaceuticals worth $1.42M as of Q1 2018.
  • Genesee Valley Trust bought 344 Regeneron Pharmaceuticals shares in Q1 2018, an estimated $120K.
  • Regeneron Pharmaceuticals made up 0.58% of Genesee Valley Trust's portfolio in Q1 2018, its #33 holding.
  • Genesee Valley Trust first reported a position in Regeneron Pharmaceuticals in Q1 2014 and has held it in 17 quarters since.
  • Genesee Valley Trust's Regeneron Pharmaceuticals position peaked at $2.6M in Q2 2017.
  • 619 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2018.

Based on Genesee Valley Trust's 13F filing for Q1 2018, filed 3 Apr 2018.